Evox Therapeutics Announces a Multi-target RNAi and Antisense Research Collaboration and License…
Evox Therapeutics Ltd announced a research collaboration and license agreement with Eli Lilly and Company to leverage Evox’s proprietary DeliverEX platform to develop and deliver RNA…
Read More...
Read More...